[12-02]Drugging the Undruggable

发布者:系统管理员发布时间:2013-11-18浏览次数:1489

报告题目:Drugging the Undruggable

人:尹航(科罗拉多大学Boulder分校化学和生物化学终身教授,生物前沿研究所研究员)

报告时间:2013122(周一)10:00

报告地点:独墅湖校区二期云轩楼2301

 

报告人简介:

尹航,现任科罗拉多大学化学和生物化学终身教授,生物前沿研究所研究员。尹航教授于1999年获得北京大学应用化学专业学士学位,2004年获得耶鲁大学(Yale University)化学系博士学位,此后在宾州大学(University of Pennsylvania 医学院从事博士后研究。 尹航教授的研究领域为交叉学科,主要涉及化学生物学,膜蛋白计算机模拟,疼痛药物研发,癌症筛查和诊断,风湿免疫疾病等领域。  尹航教授在本领域一流期刊发表研究论文约60篇,引用超过2000次,已申请专利8项(已被授予美国专利2项),并应邀在世界知名大学,国际会议上作报告超过80次。在科罗拉多大学期间,作为首席科学家 (Principal Investigator)成功获得资助总额超过9百万美元独立领导、主持超过30NIH, NSF, American Association of Cancer Research, Howard Hughes Medical InstituteAmerican Heart Association 等重大项目。尹航教授作为本领域专家,连续多年作为美国NSF基金评审小组, 美国AACR, ACS 加拿大CFI 英国MRC BBSRC 以色利ISF 以及超过40家国际期刊的评委。本小组的成果在《自然》, 美国化学会会刊《C&EN, 《美国国家科学院院刊》等杂志作为科研亮点重点报道, 在本领域内获得同行广泛认可。培养的博士后已在美国Washington State University, 美国能源部NREL国家实验室, Abbott Lab等独立领导研究组。

 

报告摘要:

The Yin lab focuses on using chemical tools (e.g. peptides, small molecules) to study biology with clinical relevance. Three major research programs are: 

(1) Transforming Clinical Pain Control by Targeting a Novel Non-Neuronal Receptor: Recent studies have shown that opioid-induced glial activation is regulated by toll-like receptor-4 (TLR4). Our  goal is to develop agents that can improve opioid-based pain management therapies. We are interested in employing rational design as well as in vitro and in vivo high-throughput screening techniques to identify novel small-molecule inhibitors of the cell surface receptors that regulate glial cell activation

(2) Probing the Development Mechanism of Epstein-Barr Virus-Dependent Lymphomas: Conventional tools such as antibodies are unable to bind to the transmembrane regions of membrane proteins. A second project in our lab is to develop exogenous peptide and small-molecule agents that target transmembrane helices. Using these agents, we can study these important membrane protein-protein interactions, thereby further our understanding of molecular recognition in membranes.

(3) Developing non-invasive biomarkers that detect membrane curvatures: . We employed a multidisciplinary approach, utilizing our expertise in computational modeling, membrane biophysics, and cellular assay development to rationally design novel tools that sense and regulate membrane curvatures.